Opportunities for the replacement of animals in the study of nausea and vomiting
Owner/Developer: British Journal of Pharmacology (BJP)
Country: | United Kingdom |
---|---|
Languages: | English |
Url: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737645/ |
Description: |
Nausea and vomiting are among the most common symptoms encountered in medicine as either symptoms of disease or side effects of treatments. Developing novel anti-emetics and identifying emetic liability in novel chemical entities rely on models that can recreate the complexity of these multi-system reflexes. Animal models (especially the ferret and dog) are the current gold standard; however, the selection of appropriate models is still a matter of debate, especially when studying the subjective human sensation of nausea. Furthermore, these studies are associated with animal suffering. Here, following a recent workshop held to review the utility of animal models in nausea and vomiting research, we discuss the limitations of some of the current models in the context of basic research, anti-emetic development and emetic liability detection. We provide suggestions for how these limitations may be overcome using non-animal alternatives, including greater use of human volunteers, in silico and in vitro techniques and lower organisms. |
Category: | Publication |
Channel: | Website - Printed |
Audience: | Scientists - Industry - Researchers |
User access: | Open access |
Updating frequency: | 2009 |
Relevance: | Replacement - Reduction - Refinement |
Purpose: | Documentation and information |
Technology/Tools: | Alternative test methods (in vitro) - Non-testing methods (in silico) |
Did you find what you were looking for?
Yes, I found it! No, I did not!Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.